相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
KLH-conjugated synthetic peptide encompassing a sequence within the N-term region of Carboxypeptidase N.
- 亚型:
Rabbit Ig
- 形态:
Each vial contains 0.1 mg IgG in 0.1 ml (1 mg/ml) of PBS pH7.4 with 0.09% sodium azide. Antibody was purified by Protein-G affinity chromatography.
- 保存条件:
Store at -20°C.
- 克隆性:
多克隆抗体
- 标记物:
见下方详细说明
- 适应物种:
H, M, R, B, X
- 宿主:
Rabbit
- 应用范围:
E, WB
- 浓度:
见详细说明信息
- 靶点:
Carboxypeptidase N
- 抗体英文名:
Carboxypeptidase N Antibody
- 抗体名:
Carboxypeptidase N抗体
- 规格:
0.1 mg
Carboxypeptidase N Antibody产品详细介绍:
| 产品名称: | Carboxypeptidase N Antibody |
| 说明书: | http://www.abbiotec.com/antibodies/carboxypeptidase-n-antibody【参考图片】 |
| 货号: | 200207 |
| 规格: | 0.1 mg |
| 产品描述: | Carboxypeptidase N (CPN1) protects the body from potent vasoactive and inflammatory peptides containing C-terminal Arg or Lys,such as kinins or anaphylatoxins, which are released into the circulatory system. |
| 克隆类型: | Rabbit Polyclonal Antibody |
| 亚型: | Rabbit Ig |
| 免疫原: | KLH-conjugated synthetic peptide encompassing a sequence within the N-term region of Carboxypeptidase N. |
| 适用物种: | H, M, R, B, X |
| 应用范围: | E, WB |
| 应用说明: | E: 1:500-1:1,000; WB: 1:100-1:500 |
| 别名: | CPN; SCPN; Carboxypeptidase N polypeptide 1; Carboxypeptidase N small subunit; Serum carboxypeptidase N; Carboxypeptidase N catalytic chain; Lysine carboxypeptidase; Arginine carboxypeptidase; Kininase-1; Anaphylatoxin inactivator; Plasma carboxypeptidase B; CPN1; ACBP |
| 形态: | Each vial contains 0.1 mg IgG in 0.1 ml (1 mg/ml) of PBS pH7.4 with 0.09% sodium azide. Antibody was purified by Protein-G affinity chromatography. |
| 保存条件: | Store at -20°C. Minimize freeze-thaw cycles. Product is guaranteed one year from the date of shipment. |
| 参考文献: | Talens S et al. 2012. Biochem Biophys Res Commun. 427(2): 421-425. PMID# 23000409. |
ABBIOTEC产品提供质量保证,提供完善的售后和技术支持,ABBIOTEC产品正品包装:
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验In the field of therapeutic recombinant proteins, monoclonal antibodies (mAbs) have achieved a rising success with more than 30 mAbs that have reached the market in the past 20 years. From a structural standpoint, one of the most important
Antibody-Directed Enzyme-Prodrug Therapy
and antibody engineering is now addressing these problems by allowing the creation of antibodies with required characteristics for specific purposes. Antibody-directed enzyme-prodrug therapy (ADEPT) is a complex two-phase system in which an enzyme is targeted
Materials 0.1M NaHC03 pH9 DMSO NHS-Biotin (N-Hydroxysuccinimidobiotin, Sigma #H-1759) PBS Procedure Dialyze the sample against carbonate buffer. After dialysis, adjust
技术资料暂无技术资料 索取技术资料










